Looking for a Washington, DC Namenda attorney? Get in touch with one of our Washington, DC Namenda attorneys now.
Namenda - MSN Newsfeeds
- BBC News - A fourth drug, memantine (Ebixa), is to be used only in clinical studies of people with moderately severe to severe Alzheimer's disease. Two companies - Eisai and Pfizer - have notified NICE that they intend to seek a judicial review of how the ...
- Connellsville Daily Courier - Aricept, Exelon and Razadyne treat mild to moderate symptoms by slowing the breakdown of a neurotransmitter critically important to memory formation. Namenda, the newest drug, treats moderate to severe symptoms by lowering levels of a ...
- PhysOrg - These include antioxidant medications, calcium channel antagonists, NMDA antagonists like the Alzheimer’s drug Memantine, platelet activating factor (PAF) inhibitors, and in the case of the new grant, drugs that inhibit glycogen synthase kinase 3 ...
- Guardian Unlimited - Another drug, Ebixa (memantine), is only to be used in clinical studies for people with moderately severe to severe Alzheimer's disease. Eisai, the licence holder of Aricept, and Pfizer, its co-promotion partner, said that Nice had been informed that ...
- Scotsman - Final guidance to be issued by NICE to the NHS in November will recommend that donepezil, galantamine and rivastigmine should only be considered in the treatment of people with moderate Alzheimer's disease. Another treatment - memantine - will only ...
- RxPG - 750,000 people are estimated to suffer from Alzheimer's disease in the UK alone, with 78,000 of these receiving rivastigmine, galantamine and memantine; a further 2-thirds of sufferers take donepezil. Since NICE's original 2001 guidelines that this ...
- PR Newswire - Namenda(R) (memantine HCl), an N-methyl-D- aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate and severe Alzheimer's disease; Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar* HCT(R ...
- HealthCentral.com - More recently, memantine (Namenda) was approved by the FDA. Memantine blocks the effects of a different chemical, glutamate, which is felt to overstimulate nerve cells and cause their degeneration. Additionally, doctors may prescribe antidepressants ...
- EurekAlert - DALLAS – Oct. 30, 2006 -- A test using cultured cells provides an effective way to screen drugs against Huntington's disease and shows that two compounds – memantine and riluzole – are most effective at keeping cells alive under conditions that ...
- Salt Lake Tribune - She swallows Namenda and Aricept for her memory. One pill helps her sleep, another pill cuts her pain, and six more prescriptions are supposed to help with a skin condition she's had for years, though she can't remember what the skin condition is and ...
- Salt Lake Tribune - She swallows Namenda and Aricept for her memory. One pill helps her sleep, another pill cuts her pain, and six more prescriptions are supposed to help with a skin condition she's had for years, though she can't remember what the skin condition is and ...
- Reuters - Analysts worried about how Forest would replace sales from its two key drugs, antidepressant Lexapro and Alzheimer's treatment Namenda. The drugs, which now represent 85 percent of sales, face patent expiration in 2011 and 2012. "Today's news means ...
- Reuters - Analysts worried about how Forest would replace sales from its two key drugs, antidepressant Lexapro and Alzheimer's treatment Namenda. The drugs, which now represent 85 percent of sales, face patent expiration in 2011 and 2012. Continued... ...
- Street.Com - For Forest, it's a setback because the New York-based company relies on licensing and marketing products from other companies, such as the antidepressant Lexapro and the Alzheimer's disease drug Namenda. Among its deals for experimental products ...
- Street.Com - For Forest, it's a setback because the New York-based company relies on licensing and marketing products from other companies, such as the antidepressant Lexapro and the Alzheimer's disease drug Namenda. Among its deals for experimental products ...
- MSN MoneyCentral - Its Alzheimer's treatment, Namenda, makes up 20 percent of its sales and will lose patent protection in 2010. Shares of Louisville, Colo.-based Replidyne, meanwhile, lost 52 percent, falling $5.34 to $4.90 in premarket trading. The stock closed at $10 ...
- MSN MoneyCentral - Namenda(R) (memantine HCl), an N-methyl- D-aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar* HCT(R ...
- Medical News Today - Last week NICE rejected five appeals against its guidance restricting the use of four drugs for Alzheimer's disease---donepezil, galantamine, rivastigmine, and memantine. The decision was met by public outrage and branded "blatant cost cutting" by ...
- Motley Fool - ... of a robust 27% to $0.75 a share over last year helped along by copious amounts of share buybacks. It also helped that sales of all three of Forest's key drugs -- Lexapro, Namenda for treating Alzheimer's disease, and anti-hypertension drug Benicar ...
- Motley Fool - Prior to the ruling, the only drug that had been approved for treating advanced symptoms of Alzheimer's was memantine, which is marketed by Forest Labs (NYSE: FRX) as Namenda. Eisai has the chance to steal a lot of business from Forest Labs, though the ...
Looking for a Washington, DC Namenda attorney? Get in touch with one of our Washington, DC Namenda attorneys now.
Pages: Previous 1 2 3 4 5 6 Next
